| Thu, Dec 10, 2009 | | • | Emisphere Technologies Reports DMC Recommendation to Proceed with Phase 3 Clinical Trials with Oral Calcitonin for Osteoporosis and Osteoarthritis
Business Wire (Thu, Dec 10)
| | Mon, Nov 30, 2009 | | • | EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Mon, Nov 30)
| | • | Emisphere Technologies Announces Extension of Maturity Date for Novartis Convertible Promissory Note
Business Wire (Mon, Nov 30)
| | Tue, Nov 24, 2009 | | • | Emisphere Technologies to Present at the New York Society of Security Analysts' 13th Annual Biotech & Specialty Pharma Investment Conference
Business Wire (Tue, Nov 24)
| | Fri, Nov 20, 2009 | | • | NYSSA Presents 13th Annual Biotech and Specialty Pharmaceuticals Conference
Business Wire (Fri, Nov 20)
| | Mon, Nov 16, 2009 | | • | EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Mon, Nov 16)
| | Fri, Nov 13, 2009 | | • | EMISPHERE TECHNOLOGIES INC Financials
EDGAR Online Financials (Fri, Nov 13)
| | Mon, Nov 9, 2009 | | • | EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Mon, Nov 9)
| | • | Emisphere Technologies Announces Financial and Operational Results for the Third Quarter and First Nine Months of 2009
Business Wire (Mon, Nov 9)
| | • | Q3 2009 Emisphere Technologies, Inc. Earnings Release - Before Market Open
CCBN (Mon, Nov 9)
| | Fri, Nov 6, 2009 | | • | EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | Emisphere Technologies Appoints Tim Rothwell to the Board of Directors
Business Wire (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | Emisphere Technologies Announces Third Quarter 2009 Conference Call
Business Wire (Wed, Nov 4)
| | Mon, Nov 2, 2009 | | • | Interim Study Data Demonstrate Eligen® B12 Oral Formulation Achieves Comparable Results to B12 Injection
Business Wire (Mon, Nov 2)
| | Thu, Oct 29, 2009 | | • | EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Thu, Oct 29)
| | Wed, Oct 21, 2009 | | • | EMISPHERE TECHNOLOGIES INC Files SEC form 10-Q/A, Quarterly Report
EDGAR Online (Wed, Oct 21)
| | Tue, Oct 20, 2009 | | • | EMISPHERE TECHNOLOGIES INC Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review
EDGAR Online (Tue, Oct 20)
| | • | Study Results: Novel Oral PTH Formulation Using Emisphere's Eligen® Technology Showed Potential Therapeutical Advantages to Available Injectable PTH in Postmenopausal Osteoporotic Women
Business Wire (Tue, Oct 20)
| | Thu, Oct 15, 2009 | | • | Study Results Suggest Oral Salmon Calcitonin Using Eligen® Drug Delivery Technology May Reduce Cartilage and Bone Degradation in Osteoarthritis
Business Wire (Thu, Oct 15)
| | Wed, Oct 14, 2009 | | • | StockPreacher.com Issues Trading Outlook for MDRNA Inc.
GlobeNewswire (Wed, Oct 14)
|
Add EMIS.OB News to My Yahoo!:
 
| |
|
0.20% Nasdaq 
Headlines
